You test positive for COVID-19, ride it out at home, and think you're done. But what happens in the months that follow? A new study tracking over 3,000 adults who weren't hospitalized for COVID found that the story often continues in the doctor's office. In the six months after their diagnosis, 69% of these patients had at least one outpatient visit. About two-thirds of those visits were for a brand new health issue, and roughly a third involved seeing a specialist. Symptoms that could be tied to COVID, like ongoing fatigue or breathing problems, were common reasons for these appointments. While these visits tended to decrease after two months, for some people, they kept happening all the way through the four-to-six-month mark. This paints a picture of COVID's lingering footprint on people's health and the healthcare system. It's important to remember this was an observational study within one specific health network in Georgia. That means it can show a pattern of people seeking care, but it can't definitively say COVID caused all these new health issues. The findings highlight a real need for ongoing support, but more research is needed to understand the full, long-term picture.
What happens after a mild COVID case? Most people need follow-up care.
Photo by Judy Beth Morris / Unsplash
What this means for you:
After mild COVID, most people see a doctor for new symptoms within six months. More on COVID-19
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders Clozapine users faced higher risk of severe COVID-19 in large study
· May 1, 2026
Inactivated SARS-CoV-2 vaccine dosing schedules and antibody responses in adults aged 60 to 80 years Older adults get better protection with the right vaccine booster timing
Frontiers · Apr 30, 2026
Survey finds physicians show stronger intergroup bias than public on vaccines Doctors Show Strong Bias Against Vaccine-Hesitant Patients
medRxiv · Apr 26, 2026
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial Metformin Cuts Long Covid Risk by 40%
CT.gov · Apr 24, 2026